Microba Life Sciences Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

ASX:MAP Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
28 Oct 25	BuyAU$594,446	Mercer Investments (Australia) Limited	Company	7,180,861	AU$0.096
17 Sep 25	SellAU$56,672	Richard Bund	Individual	690,290	AU$0.082
10 Sep 25	SellAU$156,540	Richard Bund	Individual	1,829,460	AU$0.086
28 Aug 25	SellAU$5,683,741	Perennial Value Management Limited	Company	33,605,190	AU$0.17
26 Aug 25	BuyAU$6,455,761	Perennial Value Management Limited	Company	40,544,016	AU$0.16
13 Aug 25	BuyAU$75,000	Ian Frazer	Individual	833,333	AU$0.09
13 Aug 25	BuyAU$54,000	Pasquale Rombola	Individual	600,000	AU$0.09
13 Aug 25	BuyAU$4,166,660	Sonic Healthcare Limited	Company	46,296,296	AU$0.09
27 Dec 24	BuyAU$501,771	Mercer Investments (Australia) Limited	Company	2,766,611	AU$0.19
19 Nov 24	BuyAU$34,253	Pasquale Rombola	Individual	200,000	AU$0.17
14 Nov 24	BuyAU$33,540	Ian Frazer	Individual	200,000	AU$0.17

Insider Trading Volume

Insider Buying: MAP insiders have sold more shares than they have bought in the past 3 months.

Ownership Breakdown

What is the ownership structure of MAP?
Owner Type	Number of Shares	Ownership Percentage
VC/PE Firms	35,336,905	5.8%
Private Companies	44,721,988	7.34%
Individual Insiders	80,546,612	13.2%
Institutions	112,354,327	18.5%
Public Companies	160,747,984	26.4%
General Public	175,255,218	28.8%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 36%.

Top Shareholders

Top 22 shareholders own 71.78% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
21.7%	Sonic Healthcare Limited	132,033,168	AU$10.4m	54%	100.0%
12%	Perennial Value Management Limited	73,210,184	AU$5.8m	14.1%	1.02%
5.8%	Thorney Investment Group Australia Pty. Ltd.	35,336,905	AU$2.8m	17.9%	0.43%
5.08%	Richard Bund	30,961,049	AU$2.4m	-7.53%	no data
3.95%	Mercer Investments (Australia) Limited	24,028,936	AU$1.9m	6.6%	3.11%
2.93%	Macrogen, Inc.	17,828,431	AU$1.4m	0%	no data
2.82%	Boysenholtz Pty Ltd	17,178,431	AU$1.4m	0%	no data
2.61%	Gene Tyson	15,920,000	AU$1.3m	0%	no data
2.61%	Genie Microbiome Pty Ltd	15,920,000	AU$1.3m	0%	no data
2.48%	Norges Bank Investment Management	15,115,207	AU$1.2m	12.5%	no data
1.9%	Don Maree	11,545,742	AU$912.1k	0%	no data
1.79%	Ginkgo Bioworks Holdings, Inc.	10,886,385	AU$860.0k	0%	no data
1.31%	Patrick O'Brien	8,000,000	AU$632.0k	0%	no data
1.08%	Pasquale Rombola	6,570,000	AU$519.0k	10.1%	no data
0.89%	Belgravia Strategic Equities Pty. Ltd.	5,432,342	AU$429.2k	-59.6%	no data
0.63%	Su-Ming Wong	3,838,412	AU$303.2k	0%	no data
0.56%	UniQuest Pty Limited	3,424,643	AU$270.5k	0%	no data
0.54%	Rpmt Investments Pty Ltd	3,288,715	AU$259.8k	4.4%	no data
0.48%	Derp Enterprises Pty Ltd	2,902,500	AU$229.3k	0%	no data
0.44%	Ian Frazer	2,668,235	AU$210.8k	45.4%	no data
0.087%	James Heath	531,957	AU$42.0k	0.84%	no data
0.084%	Luke Reid	511,217	AU$40.4k	0%	no data

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/11/01 09:39
End of Day Share Price	2025/10/31 00:00
Earnings	2025/06/30
Annual Earnings	2025/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Microba Life Sciences Limited is covered by 4 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Tara Speranza	Bell Potter
Thomas Wakim	Bell Potter
Elyse Shapiro	Canaccord Genuity